Bioceres Crop Solutions (NASDAQ:BIOX) Upgraded to “Strong-Buy” at Roth Capital

Roth Capital upgraded shares of Bioceres Crop Solutions (NASDAQ:BIOX) to a strong-buy rating in a report published on Tuesday morning, Zacks.com reports. Roth Capital also issued estimates for Bioceres Crop Solutions’ Q4 2024 earnings at $0.19 EPS, FY2024 earnings at $0.31 EPS, Q1 2025 earnings at $0.21 EPS, Q2 2025 earnings at $0.21 EPS, Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.26 EPS, FY2025 earnings at $0.78 EPS and FY2026 earnings at $1.19 EPS.

Separately, Roth Mkm assumed coverage on Bioceres Crop Solutions in a research report on Tuesday. They set a buy rating and a $15.00 price target for the company.

Bioceres Crop Solutions Stock Performance

NASDAQ BIOX opened at $11.08 on Tuesday. Bioceres Crop Solutions has a fifty-two week low of $10.10 and a fifty-two week high of $14.05. The stock has a market cap of $695.79 million, a price-to-earnings ratio of 1,108.00 and a beta of 0.50. The business has a fifty day moving average of $11.33 and a 200-day moving average of $12.47. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Wednesday, May 29th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The company had revenue of $83.98 million during the quarter, compared to analyst estimates of $88.80 million. Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. As a group, analysts predict that Bioceres Crop Solutions will post 0.39 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of institutional investors have recently added to or reduced their stakes in BIOX. Activest Wealth Management purchased a new stake in shares of Bioceres Crop Solutions in the first quarter worth about $30,000. Cape Investment Advisory Inc. purchased a new position in Bioceres Crop Solutions in the fourth quarter valued at about $33,000. Oppenheimer & Co. Inc. purchased a new position in Bioceres Crop Solutions in the first quarter valued at about $139,000. Lazard Asset Management LLC purchased a new position in Bioceres Crop Solutions in the first quarter valued at about $212,000. Finally, One Degree Advisors Inc purchased a new position in Bioceres Crop Solutions in the fourth quarter valued at about $291,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.